Detalhe da pesquisa
1.
Comparing the test-retest reliability of resting-state functional magnetic resonance imaging metrics across single band and multiband acquisitions in the context of healthy aging.
Hum Brain Mapp
; 44(5): 1901-1912, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36546653
2.
Rare variants in IFFO1, DTNB, NLRC3 and SLC22A10 associate with Alzheimer's disease CSF profile of neuronal injury and inflammation.
Mol Psychiatry
; 27(4): 1990-1999, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35173266
3.
Multiomics profiling of human plasma and cerebrospinal fluid reveals ATN-derived networks and highlights causal links in Alzheimer's disease.
Alzheimers Dement
; 19(8): 3350-3364, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36790009
4.
Whole-exome rare-variant analysis of Alzheimer's disease and related biomarker traits.
Alzheimers Dement
; 19(6): 2317-2331, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36464806
5.
Cerebrospinal fluid proteomic profiling of individuals with mild cognitive impairment and suspected non-Alzheimer's disease pathophysiology.
Alzheimers Dement
; 2022 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35698882
6.
Regional brain mGlu5 receptor occupancy following single oral doses of mavoglurant as measured by [11C]-ABP688 PET imaging in healthy volunteers.
Neuroimage
; 230: 117785, 2021 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33545349
7.
Pathophysiological subtypes of Alzheimer's disease based on cerebrospinal fluid proteomics.
Brain
; 143(12): 3776-3792, 2020 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33439986
8.
TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levels.
Alzheimers Dement
; 17(10): 1628-1640, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33991015
9.
Replication study of plasma proteins relating to Alzheimer's pathology.
Alzheimers Dement
; 17(9): 1452-1464, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33792144
10.
Something Is Better Than Nothing: The Value of Active Intervention in Stated Preferences for Treatments to Delay Onset of Alzheimer's Disease Symptoms.
Value Health
; 22(9): 1063-1069, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31511183
11.
Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum.
Alzheimers Dement
; 15(5): 644-654, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30853464
12.
Inflammatory biomarkers in Alzheimer's disease plasma.
Alzheimers Dement
; 15(6): 776-787, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31047856
13.
Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort.
Alzheimers Dement
; 15(6): 817-827, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31078433
14.
Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay.
Alzheimers Dement
; 15(11): 1478-1488, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31495601
15.
Test-retest reliability and longitudinal analysis of automated hippocampal subregion volumes in healthy ageing and Alzheimer's disease populations.
Hum Brain Mapp
; 39(4): 1743-1754, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29341323
16.
Making use of longitudinal information in pattern recognition.
Hum Brain Mapp
; 37(12): 4385-4404, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27451934
17.
Impact of cerebrospinal fluid matrix on the detection of Alzheimer's disease with Aß42 and influence of disease on the total-Aß42/Aß40 ratio.
J Neurochem
; 135(5): 1049-58, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26332787
18.
Accelerometer-based quantitative analysis of axial nocturnal movements differentiates patients with Parkinson's disease, but not high-risk individuals, from controls.
J Neurol Neurosurg Psychiatry
; 86(1): 32-7, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24777169
19.
Paired plasma lipidomics and proteomics analysis in the conversion from mild cognitive impairment to Alzheimer's disease.
Comput Biol Med
; 176: 108588, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38761503
20.
Evaluation of progression markers in the premotor phase of Parkinson's disease: the progression markers in the premotor phase study.
Neuroepidemiology
; 41(3-4): 174-82, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24051361